Avantor (AVTR)
Supplies laboratory and bioproduction workflows from research through production.
Something off on this page? Send us feedback.
Provides products and services for life-science and advanced-technology customers from research through production. Its VWR distribution network and bioscience products connect laboratory research with bioproduction.
VWR Distribution & Services combines the laboratory-products and services distribution network added through the VWR acquisition with a renewed VWR commercial focus. Bioscience & Medtech Products brings together bioprocessing, liquid-handling consumables, and fluid-handling capabilities expanded through RIM Bio, Ritter, and Masterflex.
Life-science and advanced-technology customers are served from research through production through an international footprint in more than 30 countries. The modern platform combines the J.T. Baker high-purity-chemicals legacy with distribution and specialized-production capabilities.
The Revival program focuses on go-to-market, VWR relaunch, operations, and e-commerce. Segment presentation moved to VWR Distribution & Services and Bioscience & Medtech Products in 2026.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 9, 2026 | UBS | Reiterate | Rating: —Target: $8 | Target: $16 |
| Jul 30, 2026 | Morgan Stanley | Reiterate | Rating: —Target: $10 | Target: $14 |
| Jul 30, 2026 | RBC Capital | Reiterate | Rating: —Target: $9 | Target: $14 |
| Jul 30, 2026 | Deutsche Bank | Reiterate | Rating: —Target: $25 | Target: $13 |
| Jul 29, 2026 | Jefferies | Upgrade | Target: $8 | Target: $13 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $306.8M · Total debt $3.70B · Total assets $11.60B · Shareholders' equity $5.63B
- Revenue
- $1.69B
- Operating income
- $121.8M
- Net income
- $38.1M
No dividends on record.
| Institutions | 104.24% | 705.01M shares | |
|---|---|---|---|
| 470 holders · as of Jun 30, 2026 | |||
| Insiders | 0.83% | 5.58M shares | |
| 24 holders · as of Aug 20, 2026 | |||
| Adds to | 105.07% | ||
676.36M company shares as of Aug 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 105.07%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Dodge & CoxInstitution | 17.75% | 120.02M | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 10.39% | 70.28M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 4.63% | 31.34M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 4.55% | 30.80M | as of Jun 30, 2026 |
Greenhaven Associates IncInstitution | 3.64% | 24.64M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 8, 2026 | Gregory T. Lucier | director | +10,000 | $8.32 |
| May 1, 2026 | Simon Dingemans | director | +25,000 | $8.14 |
| Mar 10, 2026 | Sanjeev K. Mehra | director | +125,000 | $8.01 |
| Feb 19, 2026 | Gregory T. Lucier | director | +50,000 | $9.16 |
| Feb 12, 2026 | Gregory L. Summe | director | +100,000 | $9.40 |
- Thermo Fisher Scientific
Broad laboratory distribution, reagents, consumables, and bioprocess overlap
- Danaher
Bioprocess filtration, chromatography, and single-use workflow overlap
- Agilent Technologies
Analytical laboratory instruments, consumables, software, and services overlap
- Repligen
Focused bioprocess filtration, chromatography, and fluid-management overlap
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Avantor | $15.24 | +0.93% | $10.21B | — | 17.6 | 1.6 | +0.5% |
| Thermo Fisher Scientific | $662.17 | +0.52% | $244.81B | 35.4 | 25.2 | 5.3 | +10.5% |
| Danaher | $220.95 | +2.37% | $151.67B | 38.3 | 25.0 | 6.0 | +5.5% |
| Agilent Technologies | $165.83 | +2.40% | $45.75B | 31.9 | 25.3 | 6.2 | +8.1% |
| Repligen | $187.09 | +3.53% | $10.20B | 247.5 | 82.9 | 13.0 | +11.9% |
| Median | 36.9 | 25.3 | 6.1 | +9.3% |